Circulating gamma-glutamyl transpeptidase, systemic inflammation biomarkers and risk of lung cancer in the UK biobank prospective cohort study

Abstract Epidemiological evidence on the association between Gamma-glutamyl transpeptidase (GGT) and lung cancer risk is limited. Meanwhile, whether inflammation can modify the association of GGT-lung cancer remains unknown. We assessed the relationship of GGT-lung cancer and modification effects of...

Full description

Saved in:
Bibliographic Details
Main Authors: Ting Chen, Jian Ma, Qing Zhou, Lilong Pang, Lingling Song, Xinwei Zuo, Yangjiao Bai, Xuemei Lian
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-09196-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399725059473408
author Ting Chen
Jian Ma
Qing Zhou
Lilong Pang
Lingling Song
Xinwei Zuo
Yangjiao Bai
Xuemei Lian
author_facet Ting Chen
Jian Ma
Qing Zhou
Lilong Pang
Lingling Song
Xinwei Zuo
Yangjiao Bai
Xuemei Lian
author_sort Ting Chen
collection DOAJ
description Abstract Epidemiological evidence on the association between Gamma-glutamyl transpeptidase (GGT) and lung cancer risk is limited. Meanwhile, whether inflammation can modify the association of GGT-lung cancer remains unknown. We assessed the relationship of GGT-lung cancer and modification effects of inflammation biomarkers in 412,634 participants from UK Biobank using Cox models and interactive analysis. This study founds participants in the top quartile of GGT level had an increased risk of lung cancer by 45.1% (HR, 1.451; 95% CI, 1.299–1.621; p < 0.001) compared to those in the bottom quartile. Positive associations were also observed between inflammation biomarkers (lymphocyte, neutrophil, platelet, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, white blood cell [WBC], C-reactive protein [CRP]) and lung cancer risk. Meanwhile, we observed the WBC and CRP served varying modification effects on the GGT-lung cancer associations (p interaction <0.01). As WBC level increased, the HR of GGT for lung cancer tended to increase and then decrease. However, with an increase in CRP, the HR for GGT-lung cancer significantly declined. Circulating GGT is positively associated with lung cancer. Inflammation biomarkers have mixed modification effects on the association between GGT and lung cancer. Attention should be paid to the prediction of lung cancer by WBC and CRP combined with GGT.
format Article
id doaj-art-dc80cd2ec5584fa3ab7f218cc0454d71
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-dc80cd2ec5584fa3ab7f218cc0454d712025-08-20T03:38:15ZengNature PortfolioScientific Reports2045-23222025-07-0115111010.1038/s41598-025-09196-4Circulating gamma-glutamyl transpeptidase, systemic inflammation biomarkers and risk of lung cancer in the UK biobank prospective cohort studyTing Chen0Jian Ma1Qing Zhou2Lilong Pang3Lingling Song4Xinwei Zuo5Yangjiao Bai6Xuemei Lian7Chongqing Center for Disease Control and PreventionPublic Health School, Chongqing Medical UniversityPublic Health School, Chongqing Medical UniversityPublic Health School, Chongqing Medical UniversityShapingba District Center for Disease Control and PreventionPublic Health School, Chongqing Medical UniversityPublic Health School, Chongqing Medical UniversityPublic Health School, Chongqing Medical UniversityAbstract Epidemiological evidence on the association between Gamma-glutamyl transpeptidase (GGT) and lung cancer risk is limited. Meanwhile, whether inflammation can modify the association of GGT-lung cancer remains unknown. We assessed the relationship of GGT-lung cancer and modification effects of inflammation biomarkers in 412,634 participants from UK Biobank using Cox models and interactive analysis. This study founds participants in the top quartile of GGT level had an increased risk of lung cancer by 45.1% (HR, 1.451; 95% CI, 1.299–1.621; p < 0.001) compared to those in the bottom quartile. Positive associations were also observed between inflammation biomarkers (lymphocyte, neutrophil, platelet, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, white blood cell [WBC], C-reactive protein [CRP]) and lung cancer risk. Meanwhile, we observed the WBC and CRP served varying modification effects on the GGT-lung cancer associations (p interaction <0.01). As WBC level increased, the HR of GGT for lung cancer tended to increase and then decrease. However, with an increase in CRP, the HR for GGT-lung cancer significantly declined. Circulating GGT is positively associated with lung cancer. Inflammation biomarkers have mixed modification effects on the association between GGT and lung cancer. Attention should be paid to the prediction of lung cancer by WBC and CRP combined with GGT.https://doi.org/10.1038/s41598-025-09196-4Gamma-glutamyl transpeptidaseInflammation biomarkersOxidative stressLung cancerProspective cohort study
spellingShingle Ting Chen
Jian Ma
Qing Zhou
Lilong Pang
Lingling Song
Xinwei Zuo
Yangjiao Bai
Xuemei Lian
Circulating gamma-glutamyl transpeptidase, systemic inflammation biomarkers and risk of lung cancer in the UK biobank prospective cohort study
Scientific Reports
Gamma-glutamyl transpeptidase
Inflammation biomarkers
Oxidative stress
Lung cancer
Prospective cohort study
title Circulating gamma-glutamyl transpeptidase, systemic inflammation biomarkers and risk of lung cancer in the UK biobank prospective cohort study
title_full Circulating gamma-glutamyl transpeptidase, systemic inflammation biomarkers and risk of lung cancer in the UK biobank prospective cohort study
title_fullStr Circulating gamma-glutamyl transpeptidase, systemic inflammation biomarkers and risk of lung cancer in the UK biobank prospective cohort study
title_full_unstemmed Circulating gamma-glutamyl transpeptidase, systemic inflammation biomarkers and risk of lung cancer in the UK biobank prospective cohort study
title_short Circulating gamma-glutamyl transpeptidase, systemic inflammation biomarkers and risk of lung cancer in the UK biobank prospective cohort study
title_sort circulating gamma glutamyl transpeptidase systemic inflammation biomarkers and risk of lung cancer in the uk biobank prospective cohort study
topic Gamma-glutamyl transpeptidase
Inflammation biomarkers
Oxidative stress
Lung cancer
Prospective cohort study
url https://doi.org/10.1038/s41598-025-09196-4
work_keys_str_mv AT tingchen circulatinggammaglutamyltranspeptidasesystemicinflammationbiomarkersandriskoflungcancerintheukbiobankprospectivecohortstudy
AT jianma circulatinggammaglutamyltranspeptidasesystemicinflammationbiomarkersandriskoflungcancerintheukbiobankprospectivecohortstudy
AT qingzhou circulatinggammaglutamyltranspeptidasesystemicinflammationbiomarkersandriskoflungcancerintheukbiobankprospectivecohortstudy
AT lilongpang circulatinggammaglutamyltranspeptidasesystemicinflammationbiomarkersandriskoflungcancerintheukbiobankprospectivecohortstudy
AT linglingsong circulatinggammaglutamyltranspeptidasesystemicinflammationbiomarkersandriskoflungcancerintheukbiobankprospectivecohortstudy
AT xinweizuo circulatinggammaglutamyltranspeptidasesystemicinflammationbiomarkersandriskoflungcancerintheukbiobankprospectivecohortstudy
AT yangjiaobai circulatinggammaglutamyltranspeptidasesystemicinflammationbiomarkersandriskoflungcancerintheukbiobankprospectivecohortstudy
AT xuemeilian circulatinggammaglutamyltranspeptidasesystemicinflammationbiomarkersandriskoflungcancerintheukbiobankprospectivecohortstudy